{"nct_id":"NCT00420316","title":"Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.","status":"COMPLETED","status_verified_date":"2018-07","start_date":"2007-02-12","start_date_type":"ACTUAL","primary_completion_date":"2007-08-08","primary_completion_date_type":"ACTUAL","completion_date":"2007-08-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}